文献速递中毒与环境急症呼吸衰竭与机械通气

高流量鼻导管氧疗治疗一氧化碳中毒患者碳氧血红蛋白半衰期的测定

Determination of carboxyhemoglobin half-life in patients with carbon monoxide toxicity treated with high flow nasal cannula oxygen therapy.
PubMed 文献 · Clin Toxicol (Phila) · 2019-01-28
一句话结论高流量鼻导管氧疗可使急性一氧化碳中毒患者碳氧血红蛋白半衰期约为36.8分钟,多数患者耐受良好且舒适。

本研究在两个学术急诊科开展,纳入33例急性一氧化碳中毒成人患者,评估高流量鼻导管氧疗下碳氧血红蛋白(COHb)的消除速率。患者基线COHb均值为22.5%(SD 8%),COHb半衰期均值为36.8分钟(SD 9.26分钟),22例(67%)患者在最初40分钟内COHb水平减半。20例患者未报告不耐受或不适,11例要求调整流速者中位语言数字评分从7升至调整后的9。作者认为高流量鼻导管氧疗是降低COHb简便、安全、舒适且有效的方法,可能是有前景的替代方法,但需未来研究以临床结局验证其有效性。

要点

  • 急性一氧化碳中毒成人患者接受高流量鼻导管氧疗时,COHb半衰期均值为36.8分钟(SD 9.26分钟),基线COHb均值为22.5%(SD 8%)。
  • 33例患者中22例(67%)在最初40分钟内COHb水平减半。
  • 33例患者中20例未报告高流量鼻导管氧疗不耐受或不适;11例要求改变流速者中位语言数字评分为7,降低流速后中位评分为9。
  • 作者认为高流量鼻导管氧疗是降低COHb简便、安全、舒适且有效的方法,可能是有前景的替代方法,但需未来研究以临床结局验证其有效性。

适用人群与场景

  • 因急性一氧化碳中毒就诊于急诊科的成人患者,研究在两个学术急诊科开展。

处置流程与药物剂量

  • 采用高流量鼻导管氧疗降低COHb,研究中以10分钟间隔采集静脉血样测定COHb消除速率。

研究设计与关键结果

  • 研究类型为在2017年1月至2018年2月于两个学术急诊科开展的前瞻性观察研究,共纳入33例急性一氧化碳中毒成人患者。
  • 患者基线COHb均值为22.5%(SD 8%),高流量鼻导管氧疗下COHb半衰期均值为36.8分钟(SD 9.26分钟)。
  • 22例(67%)患者在最初40分钟内COHb水平减半。
  • 33例患者中20例未报告高流量鼻导管氧疗不耐受或不适;11例要求改变流速者中位语言数字评分为7,降低流速后中位评分为9。

证据类型、等级与局限

  • 证据类型为前瞻性观察研究,原文未报告证据等级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为高流量鼻导管氧疗是降低COHb简便、安全、舒适且有效的方法。
  • 作者认为若未来研究以临床结局验证其有效性,高流量鼻导管氧疗可能是有前景的替代方法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Acute carbon monoxide poisoning is a common environmental emergency worldwide. Treatment options are limited to normobaric oxygen therapy with a nonrebreather face mask or endotracheal tube and hyperbaric oxygen. The aim of this study is to determine the half-life of carboxyhemoglobin (COHb) in adult patients admitted to the emergency department with acute carbon monoxide poisoning receiving high flow nasal cannula (HFNC) oxygen. Device tolerability and patient comfort with the high flow nasal cannula were also evaluated. Methods: This study was conducted between January 2017 and February 2018 in two academic emergency departments. Venous blood samples were obtained at 10 minute intervals to determine the rate of elimination of COHb. Patient comfort was evaluated by a verbal numeric rating scale. The primary outcome was the determination of the half-life of COHb. The secondary outcome was device tolerability and patient comfort with the high flow nasal cannula oxygen delivery system. Results: A total of 33 patients were enrolled in the study. The mean baseline COHb level of the patients was 22.5% (SD 8%). The mean half-life of carboxyhemoglobin was determined as 36.8 minutes (SD 9.26 min) with high flow nasal cannula oxygen. COHb levels were halved during the first 40 minutes in 22 (67%) of the study patients. Twenty of the patients receiving HFNC oxygen did not report intolerance or discomfort. Among the 11 patients who requested a change in the flow rate, the median verbal numeric rating score was 7. After decreasing the flow rate, the median verbal numeric rating score was 9. Conclusion: High flow nasal cannula oxygen is an easy, safe, comfortable and effective method to reduce COHb. HFNC may be a promising alternative method if it is validated as effective in future studies with clinical outcomes.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Ozturan IU, Yaka E, Suner S, et al. Determination of carboxyhemoglobin half-life in patients with carbon monoxide toxicity treated with high flow nasal cannula oxygen therapy. Clin Toxicol (Phila). 2019. PMID: 30689450. doi:10.1080/15563650.2018.1540046

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。